ISRCTN12353191
Completed
未知
A pilot randomized double-blinded single-dose provocation study on the effect of niacin on pulmonary arterial pressure
Georgetown University Institutional Review Board0 sites49 target enrollmentApril 23, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Pulmonary hypertension
- Sponsor
- Georgetown University Institutional Review Board
- Enrollment
- 49
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2015 Results article in http://www.ncbi.nlm.nih.gov/pubmed/26590128 results
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Over the age of 18
- •2\. Display a tricuspid regurgitation jet velocity over 2\.7 m/s on an inpatient echocardiogram during their current hospital stay
Exclusion Criteria
- •1\. Inability to provide written informed consent
- •2\. Known pulmonary vascular disease
- •3\. Known intolerance to niacin or current treatment with niacin
- •4\. Current treatment with a non\-steroidal anti\-inflammatory drug (NSAID)
- •5\. Known liver disease (AST/ALT \> 3x the upper limit of normal)
- •6\. Patients currently on ventilator support or using a bi\-level positive airway pressure (BiPAP) device
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinically important venous thromboembolism following lower extremity fractures: epidemiology and preventioIsolated below-knee fractures (tibia and/or fibula) requiring surgical repairInjury, Occupational Diseases, PoisoningFracturesISRCTN23254458niversity of Toronto (Canada)700
Completed
Not Applicable
Supervised Walking In comparison to Fitness Training for back paiChronic low back painMusculoskeletal DiseasesDorsalgiaISRCTN17592092Health Research Board (HRB) (Ireland)246
Completed
Phase 1
A phase I, double-blind, randomized study to evaluate the safety and immunogenicity of a new Meningococcal A Conjugate vaccine versus a Meningococcal Polysaccharide A+C reference vaccine and a Tetanus Toxoid control vaccine, given as single intramuscular injections in healthy adults from 18 to 35 years of age (India)Meningococcal diseaseInfections and InfestationsISRCTN17662153Serum Institute of India Limited (SIIL) (Secondary Sponsor - Program for Appropriate Technology in Health [PATH], USA)72
Completed
Not Applicable
CALC trial: Aprepitant for the treatment of cough in lung cancerTopic: National Cancer Research NetworkSubtopic: Lung CancerDisease: Lung (small cell), Lung (non-small cell)CancerMalignant neoplasm of bronchus and lungISRCTN16200035Christie Hospital NHS Foundation Trust (UK)20
Completed
Phase 2
A Phase II, Open-label, Randomized, Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)ISRCTN17181395Bioheart Inc. (USA)46